ConforMIS Inc. (CFMS)

1.93
0.09 4.50
NASDAQ : Health Technology
Prev Close 2.02
Open 2.02
Day Low/High 1.85 / 2.06
52 Wk Low/High 0.36 / 4.83
Volume 826.27K
Avg Volume 1.39M
Exchange NASDAQ
Shares Outstanding 68.68M
Market Cap 141.48M
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Conformis Establishes Alliance To Focus On ASC Joint Replacement

Conformis Establishes Alliance To Focus On ASC Joint Replacement

BILLERICA, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc.

Conformis To Host Second Quarter 2019 Financial Results Webcast On July 31, 2019

Conformis To Host Second Quarter 2019 Financial Results Webcast On July 31, 2019

BILLERICA, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc.

CFMS Crosses Above Average Analyst Target

CFMS Crosses Above Average Analyst Target

In recent trading, shares of Conformis Inc have crossed above the average analyst 12-month target price of $4.17, changing hands for $4.36/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Conformis Reaches Analyst Target Price

Conformis Reaches Analyst Target Price

In recent trading, shares of Conformis Inc have crossed above the average analyst 12-month target price of $3.25, changing hands for $3.29/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Short Interest In ConforMIS Moves 12.8% Higher

Short Interest In ConforMIS Moves 12.8% Higher

The most recent short interest data has been released for the 02/28/2018 settlement date, which shows a 283,951 share increase in total short interest for ConforMIS Inc , to 2,498,163, an increase of 12.82% since 02/15/2018. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Four-Year Data From The UK National Joint Registry Highlights High Survivorship In Patients Treated With The Conformis ITotal CR

Four-Year Data From The UK National Joint Registry Highlights High Survivorship In Patients Treated With The Conformis ITotal CR

Data Shows a Low Cumulative Percent Revision of 0.5% for Conformis Patients vs 1.9% for all Total Knee Replacement Patients

ConforMIS Stock Sees Short Interest Drop 30.3%

ConforMIS Stock Sees Short Interest Drop 30.3%

The most recent short interest data has been released for the 01/31/2018 settlement date, which shows a 761,165 share decrease in total short interest for ConforMIS Inc , to 1,750,599, a decrease of 30.30% since 01/12/2018. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

ConforMIS Reports Preliminary Fourth Quarter And Year-End 2017 Revenue Results; Provides 2018 Financial Guidance

ConforMIS Reports Preliminary Fourth Quarter And Year-End 2017 Revenue Results; Provides 2018 Financial Guidance

ConforMIS to Host Fourth Quarter and the Year Ended 2017 Financial Results Conference Call and Webcast on February 7, 2018

Short Interest Moves 11% Lower For CFMS

Short Interest Moves 11% Lower For CFMS

The most recent short interest data has been released for the 12/15/2017 settlement date, which shows a 325,010 share decrease in total short interest for ConforMIS Inc , to 2,616,517, a decrease of 11.05% since 11/30/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Short Interest Moves 12.2% Lower For CFMS

Short Interest Moves 12.2% Lower For CFMS

The most recent short interest data has been released for the 11/30/2017 settlement date, which shows a 409,790 share decrease in total short interest for ConforMIS Inc , to 2,941,527, a decrease of 12.23% since 11/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Leader Of Johnson & Johnson 3D Printing Center Of Excellence Outlines Advantages Of Customized Knee Implants

Leader Of Johnson & Johnson 3D Printing Center Of Excellence Outlines Advantages Of Customized Knee Implants

Orthopedic Industry Researches Additive Manufacturing and Customized Implants, While Body of Positive Clinical Results Related to ConforMIS Customized Knee Implant Systems Grows

ConforMIS Acquires Machining And Polishing Assets From Broad Peak Manufacturing

ConforMIS Acquires Machining And Polishing Assets From Broad Peak Manufacturing

Acquisition expands in-house manufacturing of customized knee implants 

ConforMIS Names Dan Krupp Senior Vice President U.S. Sales

ConforMIS Names Dan Krupp Senior Vice President U.S. Sales

ConforMIS expands leadership team with the addition of a seasoned industry professional in orthopedics and joint replacement

ConforMIS Stock Sees Short Interest Expand By 11%

The most recent short interest data has been released for the 06/15/2017 settlement date, which shows a 367,290 share increase in total short interest for ConforMIS Inc , to 3,676,553, an increase of 11.10% since 05/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

ConforMIS Announces FDA 510(k) Clearance For ITotal Hip System

New hip replacement implant system builds on ConforMIS's customized knee replacement technology and positions Company to expand in global orthopedics market

ConforMIS Becomes Oversold (CFMS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

ConforMIS Announces Positive Results From Customized ITotal PS Total Knee Replacement Comparative Study

First study of iTotal PS customized implants demonstrated more normal kinematics compared with leading off-the-shelf implants

TheStreet Quant Rating: D- (Sell)